Schizophrenia News and Research

Latest Schizophrenia News and Research

Study evaluates co-occurrence of cancers in patients with central nervous system disorders

The study evaluated the co-occurrence of cancers in patients with central nervous system disorders, including Alzheimer's disease, amyotrophic lateral sclerosis, autism spectrum disorders, Down's syndrome, Huntington's disease, multiple sclerosis, Parkinson's disease and schizophrenia.

15 Apr 2014

TSRI scientists to study effects of pain medication on prenatal brain development

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded a $472,500 Cutting Edge Basic Research Award (CEBRA) by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health to study models of the brain development of newborns who have been exposed-and become addicted-to prescription pain medication while still in the womb.

10 Apr 2014

Risk factors for complete, attempted suicide in schizophrenia 'confirmed'

Among individuals with schizophrenia, those earliest in their illness course and those with a history of suicide attempts have the highest suicide-related mortality rates, reveals analysis of the international Ziprasidone Observational Study of Cardiac Outcomes.

9 Apr 2014

Medison Pharma inks agreement with Brainsway for exclusive marketing of Deep TMS system in Israel

Medison Pharma has concluded an agreement with the medical device company Brainsway for exclusive marketing and distribution of the Deep TMS (Transcranial Magnetic Stimulation) system in Israel.

9 Apr 2014

State highlights: State mental hospitals compared to prisons; Johnson & Johnson ruling; Va. hospitals pick new leader

Arkansas Attorney General Dustin McDaniel asked the state Supreme Court on Monday to reconsider its decision tossing out a $1.2 billion judgment against drugmaker Johnson & Johnson, saying justices did "significant harm" to the state and broke from 170 years of precedent.

9 Apr 2014

Findings confirm importance of brain activity during sleep for memory strength and accuracy

The sense of smell might seem intuitive, almost something you take for granted. But researchers from NYU Langone Medical Center have found that memory of specific odors depends on the ability of the brain to learn, process and recall accurately and effectively during slow-wave sleep — a deep sleep characterized by slow brain waves.

9 Apr 2014

New project reveals mysterious processes of human brain

One of the biggest challenges today is to understand the human brain and we never have been closer to realize it. More than 130 institutes are taking part in one of Europe´s largest research projects, funded with 1.2 billion Euros: The Human Brain Project.

9 Apr 2014

Alkermes announces results from phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia

Alkermes plc today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated once monthly with either 441 mg or 882 mg of aripiprazole lauroxil demonstrated statistically significant reductions from baseline in Positive and Negative Syndrome Scale (PANSS) total scores at week 12, compared to placebo (p<0.001 aripiprazole lauroxil 441 mg, p<0.001 aripiprazole lauroxil 882 mg), which was the prespecified primary endpoint in the study. Based on the positive results from this phase 3 study, Alkermes plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the third quarter of 2014.

8 Apr 2014

Viewpoints: 'Pent-up demand' for health care; too early for that White House victory lap; the fight over Medicare advantage

More than seven million people have signed up for insurance on the new federal and state health exchanges, President Obama said this week. Millions more could be added to that total once insurers tally up the people who bought policies directly from them and when those who tried to apply on balky websites are able to complete the process.

4 Apr 2014

Study reveals role of dopamine in hippocampus region of brain

Bruno Giros, PhD, a researcher at the Douglas Mental Health University Institute and a professor in the Department of Psychiatry at McGill University, has demonstrated, for the first time, the role that dopamine plays in a region of the brain called the hippocampus.

4 Apr 2014

Cognitive dysfunction reflected in schizophrenia healthcare costs

Cognitive dysfunction has direct and indirect effects on healthcare costs in patients with schizophrenia, research suggests.

3 Apr 2014

FDA clears Omeros' OMS721 IND for inhibition of complement‑mediated TMAs

Omeros Corporation today announced that its Investigational New Drug Application (IND) to evaluate OMS721 for the inhibition of complement‑mediated thrombotic microangiopathies (TMAs) has been cleared by the U.S. Food and Drug Administration.

3 Apr 2014

Study sheds light on brain mechanisms that make schizophrenia patients misinterpret what they see

People with schizophrenia often misinterpret what they see and experience in the world. New research provides insight into the brain mechanisms that might be responsible for this misinterpretation.

3 Apr 2014

Researchers generate high-resolution blueprint for how to build human brain

Researchers at the Allen Institute for Brain Science have generated a high-resolution blueprint for how to build a human brain, with a detailed map of where different genes are turned on and off during mid-pregnancy at unprecedented anatomical resolution.

3 Apr 2014

EnVivo Pharmaceuticals changes its name to FORUM Pharmaceuticals

EnVivo Pharmaceuticals, Inc. announced today that the company has changed its name to FORUM Pharmaceuticals Inc. The new name better reflects the company's strong position as a late-stage, purpose-built organization that is focused on conquering challenging brain diseases such as schizophrenia and Alzheimer's disease.

2 Apr 2014

Experimental anticancer compound appears to reverse behaviors associated with schizophrenia

Johns Hopkins researchers say that an experimental anticancer compound appears to have reversed behaviors associated with schizophrenia and restored some lost brain cell function in adolescent mice with a rodent version of the devastating mental illness.

1 Apr 2014

Geographical variation in antipsychotic efficacy not ruled out

An individual patient data meta-analysis fails to exclude the possibility that atypical antipsychotics work better in patients from some parts of the world than others.

31 Mar 2014

Cognitive deficits in bipolar patients ‘not homogenous’

Patients with bipolar disorder can be separated into three groups based on their cognitive performance, a study suggests.

31 Mar 2014

Forest Laboratories, Richter report positive results from cariprazine Phase IIb trial for bipolar depression

Forest Laboratories, Inc. and Gedeon Richter Plc. today announced positive topline results from a Phase IIb trial evaluating the efficacy and safety of the investigational antipsychotic cariprazine in patients with bipolar depression.

31 Mar 2014

Elsevier launches open access journal addressing role of cognitive functioning in schizophrenia

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.

28 Mar 2014

Schizophrenia News and Research

Latest Schizophrenia News and Research

Study evaluates co-occurrence of cancers in patients with central nervous system disorders

TSRI scientists to study effects of pain medication on prenatal brain development

Risk factors for complete, attempted suicide in schizophrenia 'confirmed'

Medison Pharma inks agreement with Brainsway for exclusive marketing of Deep TMS system in Israel

State highlights: State mental hospitals compared to prisons; Johnson & Johnson ruling; Va. hospitals pick new leader

Findings confirm importance of brain activity during sleep for memory strength and accuracy

New project reveals mysterious processes of human brain

Alkermes announces results from phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia

Viewpoints: 'Pent-up demand' for health care; too early for that White House victory lap; the fight over Medicare advantage

Study reveals role of dopamine in hippocampus region of brain

Cognitive dysfunction reflected in schizophrenia healthcare costs

FDA clears Omeros' OMS721 IND for inhibition of complement‑mediated TMAs

Study sheds light on brain mechanisms that make schizophrenia patients misinterpret what they see

Researchers generate high-resolution blueprint for how to build human brain

EnVivo Pharmaceuticals changes its name to FORUM Pharmaceuticals

Experimental anticancer compound appears to reverse behaviors associated with schizophrenia

Geographical variation in antipsychotic efficacy not ruled out

Cognitive deficits in bipolar patients ‘not homogenous’

Forest Laboratories, Richter report positive results from cariprazine Phase IIb trial for bipolar depression

Elsevier launches open access journal addressing role of cognitive functioning in schizophrenia

Innovation in neuroscience drug discovery - eBook eBook

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

How microRNA is transforming science: From discovery to diagnostics

Schizophrenia News and Research

Latest Schizophrenia News and Research

Innovation in neuroscience drug discovery - eBook eBook

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in